CVS Caremark Rating Reiterated by TheStreet (CVS) - Mar 26th, 2013
Posted by Wayne Rhoads
CVS Caremark logoTheStreet reaffirmed their buy rating on shares of CVS Caremark (NYSE: CVS) in a report issued on Friday.
“CVS Caremark has been reiterated by TheStreet Ratings as a buy with a ratings score of A+ . The company’s strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, good cash flow from operations and increase in net income. We feel these strengths outweigh the fact that the company shows low profit margins.”
,” the firm’s analyst commented.
Other equities research analysts have also recently issued reports about the stock. Analysts at UBS AG raised their EPS on shares of CVS Caremark in a research note to investors on Thursday, March 14th. They now have a buy rating and a $60.00 price target on the stock. They previously had a $57.00 price target on the stock. Separately, analysts at Goldman Sachs downgraded shares of CVS Caremark from a buy rating to a neutral rating in a research note to investors on Tuesday, March 12th. They now have a $57.00 price target on the stock. Finally, analysts at Zacks reiterated a neutral rating on shares of CVS Caremark in a research note to investors on Tuesday, February 26th. They now have a $53.00 price target on the stock.
Two research analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the company. The company presently has an average rating of Buy and an average price target of $56.45.
Shares of CVS Caremark (NYSE: CVS) opened at 55.30 on Friday. CVS Caremark has a one year low of $43.08 and a one year high of $55.64. The stock’s 50-day moving average is currently $52.26. The company has a market cap of $68.085 billion and a P/E ratio of 18.28.
The company also recently declared a quarterly dividend, which is scheduled for Friday, May 3rd